Literature DB >> 9371713

Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene.

G B Bolger1, S Erdogan, R E Jones, K Loughney, G Scotland, R Hoffmann, I Wilkinson, C Farrell, M D Houslay.   

Abstract

We have isolated and characterized complete cDNAs for two isoforms (HSPDE4D4 and HSPDE4A5) encoded by the human PDE4D gene, one of four genes that encode cAMP-specific rolipram-inhibited 3',5'-cyclic nucleotide phosphodiesterases (type IVPDEs; PDE4 family). The HSPDE4D4 and HSPDE4D5 cDNAs encode proteins of 810 and 746 amino acids respectively. A comparison of the nucleotide sequences of these two cDNAs with those encoding the three other human PDE4D proteins (HSPDE4D1, HSPDE4D2 and HSPDE4D3) demonstrates that each corresponding mRNA transcript has a unique region of sequence at or near its 5'-end, consistent with alternative mRNA splicing. Transient expression of the five cDNAs in monkey COS-7 cells produced proteins of apparent molecular mass under denaturing conditions of 68, 68, 95, 119 and 105 kDa for isoforms HSPDE4D1-5 respectively. Immunoblotting of human cell lines and rat brain demonstrated the presence of species that co-migrated with the proteins produced in COS-7 cells. COS-cell-expressed and native HSPDE4D1 and HSPDE4D2 were found to exist only in the cytosol, whereas HSPDE4D3, HSPDE4D4 and HSPDE4D5 were found in both cytosolic and particulate fractions. The IC50 values for the selective PDE4 inhibitor rolipram for the cytosolic forms of the five enzymes were similar (0.05-0.14 microM), whereas they were 2-7-fold higher for the particulate forms of HSPDE4D3 and HSPDE4D5 (0.32 and 0.59 microM respectively), than for the corresponding cytosolic forms. Our data indicate that the N-terminal regions of the HSPDE4D3, HSPDE4D4 and HSPDE4D5 proteins, which are derived from alternatively spliced regions of their mRNAs, are important in determining their subcellular localization, activity and differential sensitivity to inhibitors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371713      PMCID: PMC1218953          DOI: 10.1042/bj3280539

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  The mRNA encoding a high-affinity cAMP phosphodiesterase is regulated by hormones and cAMP.

Authors:  J V Swinnen; D R Joseph; M Conti
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

3.  Isolation of RNA using guanidinium salts.

Authors:  R J MacDonald; G H Swift; A E Przybyla; J M Chirgwin
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Progressive sequence alignment as a prerequisite to correct phylogenetic trees.

Authors:  D F Feng; R F Doolittle
Journal:  J Mol Evol       Date:  1987       Impact factor: 2.395

5.  Cloning and expression of cDNA for a human low-Km, rolipram-sensitive cyclic AMP phosphodiesterase.

Authors:  G P Livi; P Kmetz; M M McHale; L B Cieslinski; G M Sathe; D P Taylor; R L Davis; T J Torphy; J M Balcarek
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

6.  Establishment of a near-tetraploid B-cell lymphoma line with duplication of the 8;14 translocation.

Authors:  M Nishikori; H Hansen; S Jhanwar; J Fried; P Sordillo; B Koziner; K Lloyd; B Clarkson
Journal:  Cancer Genet Cytogenet       Date:  1984-05

7.  Isolation and characterization of cDNAs corresponding to two human calcium, calmodulin-regulated, 3',5'-cyclic nucleotide phosphodiesterases.

Authors:  K Loughney; T J Martins; E A Harris; K Sadhu; J B Hicks; W K Sonnenburg; J A Beavo; K Ferguson
Journal:  J Biol Chem       Date:  1996-01-12       Impact factor: 5.157

8.  Lambda ZAP: a bacteriophage lambda expression vector with in vivo excision properties.

Authors:  J M Short; J M Fernandez; J A Sorge; W D Huse
Journal:  Nucleic Acids Res       Date:  1988-08-11       Impact factor: 16.971

9.  Microinjected antibodies against the cytoplasmic domain of vesicular stomatitis virus glycoprotein block its transport to the cell surface.

Authors:  T E Kreis
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

Review 10.  The scanning model for translation: an update.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

View more
  59 in total

Review 1.  The many dimensions of cAMP signaling.

Authors:  J H Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

Review 2.  Pharmacogenetics of asthma.

Authors:  A Fenech; Ian P Hall
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335

3.  IGF-I-induced differentiation of L6 myogenic cells requires the activity of cAMP-phosphodiesterase.

Authors:  Vania De Arcangelis; Dario Coletti; Marco Conti; Michel Lagarde; Mario Molinaro; Sergio Adamo; Georges Nemoz; Fabio Naro
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

4.  The RNA-binding protein SERBP1 interacts selectively with the signaling protein RACK1.

Authors:  Graeme B Bolger
Journal:  Cell Signal       Date:  2017-03-04       Impact factor: 4.315

5.  Evolutionarily conserved role of calcineurin in phosphodegron-dependent degradation of phosphodiesterase 4D.

Authors:  Hong Zhu; Hee Yun Suk; Raymond Y L Yu; Deborah Brancho; Opeyemi Olabisi; Teddy T C Yang; XiaoYong Yang; Jialin Zhang; Mustapha Moussaif; Jorge L Durand; Linda A Jelicks; Ja-Young Kim; Philipp E Scherer; Philippe G Frank; Michael P Lisanti; John W Calvert; Mark R Duranski; David J Lefer; Elaine Huston; George S Baillie; Miles D Houslay; Jeffrey D Molkentin; Jianping Jin; Chi-Wing Chow
Journal:  Mol Cell Biol       Date:  2010-07-20       Impact factor: 4.272

6.  The cardiac IKs potassium channel macromolecular complex includes the phosphodiesterase PDE4D3.

Authors:  Cecile Terrenoire; Miles D Houslay; George S Baillie; Robert S Kass
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

7.  Mdm2 directs the ubiquitination of beta-arrestin-sequestered cAMP phosphodiesterase-4D5.

Authors:  Xiang Li; George S Baillie; Miles D Houslay
Journal:  J Biol Chem       Date:  2009-04-16       Impact factor: 5.157

8.  Mice deficient in phosphodiesterase-4A display anxiogenic-like behavior.

Authors:  Rolf T Hansen; Marco Conti; Han-Ting Zhang
Journal:  Psychopharmacology (Berl)       Date:  2014-02-22       Impact factor: 4.530

9.  Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.

Authors:  P H Schafer; A Parton; A K Gandhi; L Capone; M Adams; L Wu; J B Bartlett; M A Loveland; A Gilhar; Y-F Cheung; G S Baillie; M D Houslay; H-W Man; G W Muller; D I Stirling
Journal:  Br J Pharmacol       Date:  2009-12-24       Impact factor: 8.739

10.  Refolding and kinetic characterization of the phosphodiesterase-8A catalytic domain.

Authors:  Zier Yan; Huanchen Wang; Jiwen Cai; Hengming Ke
Journal:  Protein Expr Purif       Date:  2008-10-19       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.